KR20080059702A - Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3 - Google Patents

Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3 Download PDF

Info

Publication number
KR20080059702A
KR20080059702A KR1020060133334A KR20060133334A KR20080059702A KR 20080059702 A KR20080059702 A KR 20080059702A KR 1020060133334 A KR1020060133334 A KR 1020060133334A KR 20060133334 A KR20060133334 A KR 20060133334A KR 20080059702 A KR20080059702 A KR 20080059702A
Authority
KR
South Korea
Prior art keywords
pgl3
enhancer
carrier
bmnpv
recombinant protein
Prior art date
Application number
KR1020060133334A
Other languages
Korean (ko)
Inventor
구태원
윤은영
최광호
손봉희
강석우
김성완
권오유
Original Assignee
대한민국(관리부서:농촌진흥청장)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대한민국(관리부서:농촌진흥청장) filed Critical 대한민국(관리부서:농촌진흥청장)
Priority to KR1020060133334A priority Critical patent/KR20080059702A/en
Publication of KR20080059702A publication Critical patent/KR20080059702A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14041Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A hr3(homologous region 3) enhancer isolated from Bombyx mori nucleopolyhedrovirus K1 is provided to maximize the activity of promoter and produce a large quantity of a recombinant protein by optimizing the location and direction of the enhancer in the expression vector. A hr3 enhancer isolated from Bombyx mori nucleopolyhedrovirus K1 has the nucleotide sequence of SEQ ID NO:1. The mass-production of a recombinant protein is accomplished by locating the hr3 enhancer of SEQ ID NO:1 in a site downstream of the SV40 poly A site in 3' to 5' direction in a protein expression vector.

Description

누에 핵다각체 바이러스로부터 분리한 에이치알3 엔핸서 및 이를 이용한 재조합단백질 생산방법{Hr3 enhancer from Bombyx mori nucleopolyhedrovirus K1 and construction of method for mass production of a recombinant protein using hr3}Hr3 enhancer from Bombyx mori nucleopolyhedrovirus K1 and construction of method for mass production of a recombinant protein using hr3}

도 1은 BmNPV K1로부터 분리한 hr3 영역을 염기서열을 분석한 후, 기존에 밝혀진 hr3 영역에 대하여 상동성 분석을 수행한 결과이다(도 1a는 BmNPV K1로부터 분리한 hr3 영역의 염기서열을 나타낸다. 도 1b 및 도 1c는 본 연구에서 분리한 BmNPV K1의 hr3 염기서열과 기존에 밝혀진 3종의 BmNPV hr3와의 상동성을 비교한 결과로써, BMU77353, BMU51238 및 L24902는 GenBank에 등록된 3종의 hr3의 등록번호를 나타내며, BmNPV K1은 본 발명에서 분리한 BmNPV K1의 hr3를 나타낸다).FIG. 1 shows the results of nucleotide sequence analysis of the hr3 region separated from BmNPV K1, followed by homology analysis of the previously known hr3 region (FIG. 1A shows the nucleotide sequence of the hr3 region separated from BmNPV K1). 1B and 1C show the homology between the hr3 nucleotide sequence of BmNPV K1 isolated in this study and the three previously identified BmNPV hr3.BMU77353, BMU51238 and L24902 are the three hr3s registered in GenBank. BmNPV K1 represents the hr3 of BmNPV K1 isolated in the present invention).

도 2A는 분리한 hr3의 5’→ 3’ 방향 및 3’→ 5’방향에 KpnⅠ, NheⅠ, BamHⅠ 및 SalⅠ 인식서열을 부여하여, KpnⅠ- 5’→ 3’-NheⅠ(U-53), KpnⅠ- 3’→ 5’-NheⅠ(U-35), BamHⅠ- 5’→ 3’-SalⅠ(D-53) 및 BamHⅠ- 3’→ 5’-SalⅠ(D-35) 4종의 hr3 삽입 유전자(insert)를 제작한 다음, 누에의 hypothetical protein 32 (Hp32) 프로모터 하류에 표지유전자로 반딧불이 (firefly) 루시퍼레이즈 유전자를 포함하고 있는 pGL3-Hp32 운반체의 Hp32 프로모터 상류와 SV40 폴리 A 하류에 도입하여, pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반체를 제작한 운반체를 나타낸다. 도 2B는 제작한 4종의 pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반체의 표준화 (normalization)를 위한 표준화 운반체인 pRL-A3-Rluc를 제작한 것이다. 2A is given to the Kpn Ⅰ, Nhe Ⅰ, BamH Ⅰ and Sal Ⅰ recognition sequence in 5 '→ 3' direction and a 3 '→ 5' direction of the separation hr3, Kpn Ⅰ- 5 '→ 3'- Nhe Ⅰ ( U-53), Kpn I-3 '→ 5'- Nhe I (U-35), BamH I-5' → 3'- Sal I (D-53) and BamH I-3 '→ 5'- Sal I (D-35) Hp32 of the pGL3-Hp32 transporter containing four fire hr3 insert genes containing a firefly luciferase gene downstream of the silkworm hypothetical protein 32 (Hp32) promoter as a marker gene. Carriers produced upstream of the promoter and downstream of the SV40 Poly A were constructed with pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 and pGL3-Hp32-D35 carriers. FIG. 2B shows a standardized carrier pRL-A3-R luc for normalization of four pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53, and pGL3-Hp32-D35 carriers. It is.

도 3은 대조 운반체인 pGL3-Hp32와 제작한 4종의 pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반체에 대한 루시퍼레이즈 활성을 분석한 결과이다.Figure 3 shows the results of analysis of luciferase activity against the control carrier pGL3-Hp32 and four types of pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 and pGL3-Hp32-D35 carrier.

본 발명은 누에 핵다각체 바이러스로부터 분리한 hr3 엔핸서의 발현운반체 내 최적 도입위치 및 도입방향에 관한 것이다The present invention relates to the optimal introduction position and the introduction direction of the expression carrier of the hr3 enhancer isolated from the silkworm polyhedral virus

베큘로바이러스의 상동성 영역(homologous regions; hrs)은 베큘로바이러스의 게놈 내에 반복된 염기서열을 가지는 영역을 의미한다. 현재까지, 베큘로바이러스의 상동성 영역들은 Bombyx mori Nucleopolyhedrovirus (BmNPV)를 포함하여 Autographa californica NPV (AcNPV), Lymantria dispar NPV (LdNPV), Orgyoa psudotsugagta NPV ((OpNPV) 등에서 분리되었다(Lu et al., 1997). BmNPV T3 게놈에는 7개의 hr1, hr2L, hr2R, hr3, hr4L, hr4R 및 hr5가 존재한다(Gomi et al., 1999). 그리고 이들 상동성 영역의 대부분이 바이러스 DNA 복제에 있었어 매우 중요한 역할을 할 뿐만 아니라, 바이러스 및 비바이러스 유전자의 전사를 위한 엔핸서(enhancer)로써의 기능을 가지는 것이 확인되었다(Lo et al., 2002, Viswanathan et al., 2003). 따라서, 최근에는 이 hr3를 재조합단백질 발현을 위한 엔핸서로 이용하고자 하는 많은 연구가 진행되었으며, 실질적으로 단백질 발현운반체 내 hr3를 도입하여 hr3를 도입하지 않은 운반체에 비하여 훨씬 과량의 표지 유전자가 발현된다는 것이 확인되었다(Gray et al., 2004, Tang et al., 2005, Nagamine et al., 2005).Homologous regions (hrs) of baculovirus refer to regions having repeated sequences in the genome of baculovirus. To date, homologous regions of baculovirus are known as Bombyx Autographa including mori Nucleopolyhedrovirus (BmNPV) californica NPV (AcNPV), Lymantria dispar NPV (LdNPV), Orgyoa psudotsugagta NPV ((OpNPV), etc. (Lu et al., 1997) .There are seven hr1, hr2L, hr2R, hr3, hr4L, hr4R and hr5 in the BmNPV T3 genome (Gomi et al., 1999). Most of these homologous regions have been shown to play a very important role in viral DNA replication, as well as to function as enhancers for transcription of viral and nonviral genes (Lo et al., 2002, Viswanathan et al., 2003) Therefore, much research has recently been conducted to use this hr3 as an enhancer for expression of recombinant proteins, and it has been substantially improved compared to a vehicle which does not introduce hr3 by introducing hr3 in a protein expression carrier. Excess marker genes were identified (Gray et al., 2004, Tang et al., 2005, Nagamine et al., 2005).

그러나 이 hr3 엔핸서가 유용 재조합단백질 발현을 위한 발현운반체 내의 어떤 위치에 어떤 방향으로 도입했을 때, 프로모터의 활성을 최대로 증대시킬 수 있는지에 관한 연구는 전무한 실정이다.However, there are no studies on how the hr3 enhancer can maximize the activity of the promoter when introduced into which position in the expression carrier for expression of useful recombinant protein.

본 발명자들은 BmNPV K1에서 분리한 hr3 영역에 대하여 단백질 발현운반체 내 최적 도입위치와 도입방향을 결정함으로써, hr3 영역을 도입하지 않은 운반체에 비하여 약 3배의 재조합단백질 발현을 향상시킴으로써 본 발명을 완성하게 되었다.The present inventors have completed the present invention by determining the optimal introduction position and introduction direction in the protein expression carrier for the hr3 region isolated from BmNPV K1, thereby improving the expression of recombinant protein about three times as compared to the carrier without introducing the hr3 region. It became.

따라서, 본 발명의 목적은 BmNPV K1의 hr3 영역에 대하여 단백질 발현운반체 내 최적 도입위치와 도입방향을 제공하는 것이다.Accordingly, it is an object of the present invention to provide an optimal introduction position and introduction direction in a protein expression carrier for the hr3 region of BmNPV K1.

누에 핵다각체바이러스(BmNPV K1)로부터 분리한 hr3 엔핸서의 발현운반체 내 최적 도입위치 및 도입방향을 결정하기 위하여 본 발명은,In order to determine the optimal introduction position and introduction direction in the expression carrier of the hr3 enhancer isolated from silkworm polyhedron virus (BmNPV K1),

1) 기존에 분리된 BmNPV T3 스트레인의 hr3 영역에 대한 프라이머를 합성한 다음, BmNPV K1 스트레인의 게놈을 주형으로 하여 PCR를 수행하여 BmNPV K1의 hr3 영역를 증폭하는 단계,1) synthesizing primers for the hr3 region of the previously isolated BmNPV T3 strain, amplifying the hr3 region of BmNPV K1 by performing PCR using the genome of the BmNPV K1 strain as a template;

2) 상기 단계 1)에서 증폭된 BmNPV K1의 hr3 영역을 pGEM-T easy 운반체 (Promega, USA)에 클로닝하여 pGEMT-hr3 운반체를 제작하는 단계,2) preparing a pGEMT-hr3 carrier by cloning the hr3 region of BmNPV K1 amplified in step 1) into a pGEM-T easy carrier (Promega, USA),

3) 상기 단계 2)에서 제작된 pGEMT-hr3 운반체 내 hr3에 대하여 전체 염기서열을 분석하는 단계,3) analyzing the entire base sequence for hr3 in the pGEMT-hr3 carrier prepared in step 2),

4) 상기 단계 3)에서 분리하여 염기서열을 분석한 BmNPV K1의 hr3 영역을 누에의 hypothetical protein 32 (Hp32) 프로모터 하류에 표지유전자로 루시퍼레이즈 유전자를 포함하고 있는 pGL3-Hp32 운반체 (농과원 생체정보연구실 보유)의 누에 Hp32 프로모터 상류와 SV40 폴리 A 하류에 각각 5’ → 3’ 방향과 3’ → 5’방향으로 도입하여 pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반체를 제작하는 단계, 및4) The pGL3-Hp32 carrier (Lucifer Bioinformatics Lab.) Containing the luciferase gene as a marker gene downstream of the hypothetical protein 32 (Hp32) promoter of the silkworm in the hr3 region of BmNPV K1 isolated from step 3). Silkworm Hp32 promoter upstream and downstream of SV40 poly A in the 5 '→ 3' and 3 '→ 5' directions, respectively, for pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 and pGL3- Fabricating the Hp32-D35 carrier, and

5) 상기 단계 4)에서 제작한 4종의 pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반체와 대조 운반체인 pGL3-Hp32 운반체 각각에 대하여 루시퍼레이즈 활성을 검정하는 단계;를 포함하는 방법에 의해서, 누에 핵다각체바이러스 (BmNPV K1)로부터 분리한 hr3 엔핸서의 발현운반체 내 최적 도입위치 및 도입방향을 결정함을 특징으로 한다.5) Luciferase activity against each of the four pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 and pGL3-Hp32-D35 carriers prepared in step 4) and the control carrier pGL3-Hp32 carrier By the method comprising the, characterized in that for determining the optimal introduction position and introduction direction in the expression carrier of the hr3 enhancer isolated from silkworm polyhedron virus (BmNPV K1).

본 발명에서 개발한 hr3 영역의 발현운반체 내 최적 도입위치 및 도입방향을 결정하기 위하여, 누에의 hypothetical protein 32 (Hp32) 프로모터 하류에 표지유전자로 루시퍼레이즈 유전자를 포함하고 있는 pGL3-Hp32 운반체의 누에 Hp32 프로모터 상류와 SV40 폴리 A 하류에 각각 hr3를 5’ → 3’ 방향과 3’ → 5’방향으로 도입하여 pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반 체를 제작하였다. 대조 운반체인 pGL3-Hp32 운반체를 포함하여 제작한 4종의 운반체에 대해서는 Dual Luciferase Assay System (Promega, USA)을 이용하여 루시퍼레이즈 활성을 비교 분석하였다. In order to determine the optimal introduction position and the direction of introduction in the expression carrier of the hr3 region developed in the present invention, the silkworm Hp32 of the pGL3-Hp32 carrier containing a luciferase gene downstream of the hypothetical protein 32 (Hp32) promoter of silkworms. Hr3 is introduced in the 5 '→ 3' and 3 '→ 5' directions upstream of the promoter and downstream of the SV40 poly A, respectively, for pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 and pGL3-Hp32-D35 The carrier was produced. Four different carriers, including the control vehicle, pGL3-Hp32, were compared for luciferase activity using the Dual Luciferase Assay System (Promega, USA).

이하 본 발명을 하기 실시예에 의해서 보다 구체적으로 설명하지만, 본 발명의 보호범위가 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the protection scope of the present invention is not limited to the following examples.

실시예Example 1.  One. BmNPVBmNPV K1K1 of hr3hr3 영역을 분리하고 염기서열을 해독하는 단계 Isolating Regions and Decoding Sequences

베큘로바이러스 BmNPV K1 스트레인의 hr3 영역을 분리하기 위하여, 기존에 밝혀진 BmNPV T3 스트레인 (strain) 게놈의 hr3 영역에 대한 forward 프라이머 (5’-ACATTTTATGTCGAAAACAAATGAC-3')와 reverse 프라이머 (5'-CATATGAGCAGACCCGTCTTGGCGA-3')를 각각 합성하였다. 합성한 forward 프라이머와 reverse 프라이머는 BmNPV K1 스트레인의 게놈을 주형으로한 PCR 반응에 사용하였다. PCR 반응에 의해 증폭된 PCR 산물은 pGEM-T easy 운반체에 클로닝하여 pGEMT-hr3 운반체를 제작한 다음, hr3 영역에 대하여 전체 염기서열 분석하였다(도 1참조). 도1B에 나타낸 바와 같이 BmNPV KI 스트레인(한국종)의 hr3 염기서열은 기존에 보고된 일본종 및 중국종과 서열적 차이를 나타냄을 알 수 있다.To isolate the hr3 region of the baculovirus BmNPV K1 strain, a forward primer (5'-ACATTTTATGTCGAAAACAAATGAC-3 ') and a reverse primer (5'-CATATGAGCAGACCCGTCTTGGCGA-3) for the hr3 region of the previously identified BmNPV T3 strain genome ') Was synthesized respectively. The synthesized forward and reverse primers were used for PCR reactions based on the genome of the BmNPV K1 strain. The PCR product amplified by the PCR reaction was cloned into a pGEM-T easy carrier to prepare a pGEMT-hr3 carrier, followed by full sequencing of the hr3 region (see FIG. 1). As shown in FIG. 1B, the hr3 nucleotide sequence of the BmNPV KI strain (Korean species) shows a sequence difference from the previously reported Japanese and Chinese species.

실시예Example 2. 분리한  2. Separated BmNPVBmNPV K1K1 hr3hr3 의 단백질 발현운반체 내 최적 도입위치 및 도입방향 결정을 위한 4종의 운반체 제작Four Carriers for the Determination of Optimal Positions and Directions for Protein Expression Carriers

상기 실시예 1에서 분리한 BmNPV K1 hr3의 5’→ 3’ 방향 및 3’→ 5’방향 의 말단 서열에 KpnⅠ (GGTACC), NheⅠ (GCTAGC), BamHⅠ (GGATCC) 및 SalⅠ (GTCGAC) 인식서열을 부여 (flanking)하여 forward 및 reverse 프라이머를 합성하였다. 합성한 각각의 forward 프라이머와 reverse 프라이머는 pGEMT-hr3를 주형으로한 PCR 반응에 사용하였다. PCR 반응에 의해 증폭된 KpnⅠ- 5’→ 3’-NheⅠ(U-53), KpnⅠ- 3’→ 5’-NheⅠ(U-35), BamHⅠ- 5’→ 3’-SalⅠ(D-53) 및 BamHⅠ- 3’→ 5’-SalⅠ(D-35) PCR 산물은 pGEM-T easy 운반체에 각각 클로닝하여, pGEMT-U53, pGEMT-U35, pGEMT-D53 및 pGEMT-D35를 제작하였다. 제작한 pGEMT-U53와 pGEMT-U35는 각각 제한효소 KpnⅠ과 NheⅠ으로 동시에 처리한 다음, 누에의 hypothetical protein 32 (Hp32) 프로모터 하류에 표지유전자로 반딧불이 (firefly) 루시퍼레이즈 유전자를 포함하고 있는 pGL3-Hp32 운반체 내 Hp32 프로모터 상류의 제한효소 위치인 KpnⅠ과 NheⅠ 사이에 각각 도입하여, 2종의 pGL3-U53-Hp32와 pGL3-U35-Hp32 운반체를 제작하였다. 나머지 2종의 pGEMT-D53와 pGEMT-D35는 각각 BamHⅠ과 SalⅠ으로 동시에 처리한 다음, pGL3-Hp32 운반체 내 SV40 폴리 A 하류의 제한효소 위치인 BamHⅠ과 SalⅠ 사이에 각각 도입하여, pGL3-Hp32-D53과 pGL3-Hp32-D35를 제작하였다 (도 2A 참조).The terminal sequence of the embodiment 15 of the BmNPV K1 hr3 isolated from '→ 3' direction and a 3 '→ 5' direction Kpn Ⅰ (GGTACC), Nhe Ⅰ (GCTAGC), Bam HⅠ (GGATCC) and Sal Ⅰ (GTCGAC ) Flanking was used to synthesize forward and reverse primers. Each of the forward and reverse primers synthesized was used for PCR reaction with pGEMT-hr3 as a template. Amplified by the PCR reaction Kpn Ⅰ- 5 '→ 3'- Nhe Ⅰ (U-53), Kpn Ⅰ- 3' → 5'- Nhe Ⅰ (U-35), Bam HⅠ- 5 '→ 3'- Sal PCR products of I (D-53) and Bam HI-3 '→ 5'- Sal I (D-35) were cloned into pGEM-T easy carriers, respectively, for pGEMT-U53, pGEMT-U35, pGEMT-D53 and pGEMT- D35 was produced. PGEMT-U53 and pGEMT-U35 were treated with restriction enzymes Kpn I and Nhe I, respectively, and then pGL3 containing a firefly luciferase gene downstream of the silkworm hypothetical protein 32 (Hp32) promoter. respectively introduced between the carrier -Hp32 Hp32 within the Kpn ⅰ and Nhe ⅰ restriction position upstream of the promoter, to prepare a pGL3-U53-U35-Hp32 Hp32 and pGL3-carriers of two or more. The remaining two of pGEMT-D53 and pGEMT-D35 are respectively introduced between the respective Bam HⅠ and Sal Ⅰ in one process at the same time and then, pGL3-Hp32 carriers within the SV40 poly (A) downstream of the restriction endonuclease site is Bam HⅠ and Sal Ⅰ, pGL3 -Hp32-D53 and pGL3-Hp32-D35 were constructed (see Figure 2A).

또 한편으로, 제작한 4종의 운반체 (pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35)에 대한 표준화 (normalization)를 위한 표준화 운반체 제작은 표지 유전자로 Renilla 루시퍼레이즈 유전자를 포함하고 있는 pRL-SV40 운반체 (Promega, USA)에서 SV40 프로모터를 제한효소 KpnⅠ과 HindⅢ로 처리하여 제거한 다음, 그 위치에 누에의 액틴3 (A3 cytoplasmic actin gene) 프로모터를 도입 하여, 반딧불이 (firefly) 루시퍼레이즈 활성을 표준화 할 수 있는 표준화 운반체인 pRL-A3-Rluc를 제작하였다 (도 2B).On the other hand, the production of standardized carriers for normalization of the four types of carriers (pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53, and pGL3-Hp32-D35) were used as marker genes. In the pRL-SV40 carrier (Promega, USA) containing the Renilla luciferase gene, the SV40 promoter was removed by restriction enzymes Kpn I and Hind III, and then the silkworm actin 3 (A3 cytoplasmic actin gene) promoter was introduced at that position. Thus, pRL-A3-R luc , a standardized carrier capable of standardizing firefly luciferase activity, was prepared (FIG. 2B).

실시예Example 3.  3. pGL3pGL3 -- Hp32Hp32 운반체를  Carrier 대조로한By contrast 4종의  4 kinds pGL3pGL3 -- U53U53 -- Hp32Hp32 , , pGL3pGL3 -- U35U35 -- Hp32Hp32 , , pGL3pGL3 -- Hp32Hp32 -- D53D53 및 pGL3-Hp32-D35 운반체 각각에 대한  For each of the and pGL3-Hp32-D35 carriers 루시퍼레이즈Luciferase 활성 분석 Activity analysis

제작한 hr3에 대하여 도입위치와 도입방향이 각기 다른 4종의 운반체인 pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35와 대조 운반체 pGL3-Hp32에 대한 루시퍼레이즈 활성검정은 Dual-Luciferase Reporter Assay System (Promega, USA)을 이용하여 수행하였다. 즉, pGL3-hp32, pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53 및 pGL3-Hp32-D35 운반체 각각에 대한 400ng과 표준화 운반체인 pRL-A3-Rluc 40ng를 멸균증류수 25㎕에 각각 혼합한 다음, 세포내 핵산 도입 시약인 FuGENE HD Transfection Reagent (Roche, USA) 2㎕를 다시 혼합하여, 24 well 플레이트에서 생장하고 있는 Bm5 누에 배양세포주에 처리하였다. 처리 48시간 후에 배양액을 제거하고 1X PBS 용액으로 수세한 다음, 1X Passive Lysis Buffer 100㎕를 부가하여 15분간 회전교반하여 배양세포를 분해시켰다.Lucifer for four carriers, pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53, pGL3-Hp32-D35, and the control carrier pGL3-Hp32, each having a different introduction position and introduction direction. Raise activity assay was performed using the Dual-Luciferase Reporter Assay System (Promega, USA). In other words, 400 μl of pGL3-hp32, pGL3-U53-Hp32, pGL3-U35-Hp32, pGL3-Hp32-D53, and pGL3-Hp32-D35 carriers and 40 ng of standardized carrier, pRL-A3-R luc 40 ng, were added to 25 μl of sterile distilled water. 2 μl of FuGENE HD Transfection Reagent (Roche, USA), an intracellular nucleic acid introduction reagent, was mixed again and treated with Bm5 silkworm cultured cell lines grown in 24 well plates. After 48 hours of treatment, the culture medium was removed, washed with 1X PBS solution, and 100 µl of 1X Passive Lysis Buffer was added thereto, followed by rotary stirring for 15 minutes to decompose the cultured cells.

96 well white 플레이트(Greiner bio-one, Germany)에 1X Firefly Luciferase Assay ReagentⅡ 100㎕를 5개의 well에 분주한 다음, 각각의 well에 상기에서 준비한 각각의 세포 분해물(cell lysate) 20㎕를 혼합한 후, luminometer(TECAN, USA)를 이용하여 대조 운반체를 포함한 4종의 hr3 운반체에 대 한 firefly 루시퍼레이즈 활성을 측정하였다.Dispense 100 μl of 1 × Firefly Luciferase Assay Reagent II into 5 wells on a 96 well white plate (Greiner bio-one, Germany), mix 20 μl of each cell lysate prepared above in each well, and Firefly luciferase activity was measured for four hr3 carriers, including the control vehicle, using a luminometer (TECAN, USA).

Firefly 루시퍼레이즈 활성을 표준화(normalization) 시키기 위하여, firefly 루시퍼레이즈 활성측정 직후에, firefly 루시퍼레이즈 활성억제 및 Renilla 루시퍼레이즈 활성측정 용액인 1X Stop & Glo Subtrate 100㎕를 부가한 다음, luminometer (TECAN, USA)를 이용하여 각각의 대조 운반체를 포함한 4종의 hr3 운반체에 대한 Renilla 루시퍼레이즈 활성을 측정하였다. 루시퍼레이즈 활성 측정은 3반복으로 수행하였다.To normalize Firefly luciferase activity, immediately after firefly luciferase activity measurement, 100 μl of 1X Stop & Glo Subtrate, a firefly luciferase activity inhibitor and Renilla luciferase activity assay solution, was added, followed by a luminometer (TECAN, USA ), Renilla luciferase activity was measured for four hr3 carriers, including each control vehicle. Luciferase activity measurements were performed in three replicates.

Luminometer에 의해 측정된 각각의 운반체에 대한 firefly 루시퍼레이즈 측정값은 각각의 운반체에 대하여 측정된 Renilla 루시퍼레이즈 측정값으로 나누어 표준화(normalization) 하였다.Firefly luciferase measurement for each of the carrier measured by a Luminometer is a Renilla measurement for each carrier The normalization was divided by the luciferase measurement.

이때, 대조 운반체인 pGL3-Hp32의 표준화 값을 100으로 설정한 다음, 4종의 hr3 운반체에 대해서는 상대값으로 계산하였다. 도 3에서 나타난 것처럼 pGL3-Hp32-D35 운반체의 상대값이 287.1%로 가장 높게 나타났으며, pGL3-U53-Hp32, pGL3-U35-Hp32 및pGL3-Hp32-D53의 상대값은 각각 150.9%, 145% 및 171.8%로 비교적 낮게 나타났다.At this time, the normalized value of the control carrier pGL3-Hp32 was set to 100, and then calculated as relative values for the four hr3 carriers. As shown in FIG. 3, the relative value of the pGL3-Hp32-D35 carrier was 287.1%, and the relative values of pGL3-U53-Hp32, pGL3-U35-Hp32, and pGL3-Hp32-D53 were 150.9% and 145, respectively. % And 171.8% were relatively low.

따라서 누에 핵다각체 바이러스로부터 분리한 hr3 엔핸서의 발현운반체 내 최적 도입위치 및 도입방향은 hr3 영역을 3’→ 5’방향으로 SV40 폴리 A 하류에 도입하였을 때 가장 과량의 재조합단백질을 생산할 수 있을 것으로 판단되었다.Therefore, the optimal introduction position and direction in the expression carrier of hr3 enhancer isolated from silkworm polyhedron virus will be able to produce the most excess recombinant protein when hr3 region is introduced downstream of SV40 poly A in 3 '→ 5' direction. Judging.

누에 핵다각체 바이러스 (BmNPV)로부터 분리한 hr3는 앤핸서(enhancer)로써 의 기능이 확인되어, 유용재조합단백질 발현을 위한 프로모터의 앤핸서로써 이용되고 있다. 그러나 hr3 엔핸서가 유용 재조합단백질 발현을 위한 단백질 발현운반체 내의 어떤 위치에 어떤 방향으로 도입했을 때, 프로모터의 활성을 최대로 증대시킬 수 있는지에 관한 연구는 전무한 실정이다. 따라서 본 발명에서 개발한 hr3 영역의 단백질 발현운반체 내 최적 도입위치 및 도입방향의 결정은 동일한 노력으로 보다 과량의 유용 재조합단백질을 생산하는데 유용하게 이용될 것이다.The hr3 isolated from the silkworm polyhedron virus (BmNPV) has been confirmed to function as an enhancer and has been used as an enhancer for promoters for the expression of useful recombinant proteins. However, no studies have been conducted on how the hr3 enhancer can maximize the activity of the promoter when introduced into which position in the protein expression carrier for expression of useful recombinant protein. Therefore, the determination of the optimal introduction position and introduction direction in the protein expression carrier of the hr3 region developed in the present invention will be usefully used to produce more useful recombinant protein in the same effort.

<110> Rural Development Administration <120> Optimal location and direction of hr3 enhancer from Bombyx mori nucleopolyhedrovirus in expression vector <130> 1 <160> 1 <170> KopatentIn 1.71 <210> 1 <211> 461 <212> DNA <213> hr3 from Bombys mori nucleopolyhedrovirus <400> 1 acattttatg tcgaaaacaa atgacatcag cttatgattc atacttaatc gtgcgttaca 60 agtagaattc tactcgtaaa gcgagtttaa tttgaaaaac aaattagtca ttattaaaca 120 tgttaacaat cgtgtataaa aatgacatca gtttaatgat gacatcatct cttgattatg 180 ttttacacgt agaattctac tcgtaaagcc agttcagttt tgaaaaacaa atgacatcat 240 ctttcgatta tgttttacac gtagaattct actcgtaaag ccagttcagt tttgaaaaac 300 aaatgacatc atttcttaaa ttcggttttg aaaaacaaat gacatcatct cttgattgtg 360 ttttacacgt agaattctac tcgtaaagcc agttcaattt tgaaaaacaa atgacatcat 420 cttagaggta gactcgtcgc caagacgggt ctgctcatat g 461 <110> Rural Development Administration <120> Optimal location and direction of hr3 enhancer from Bombyx mori          nucleopolyhedrovirus in expression vector <130> 1 <160> 1 <170> KopatentIn 1.71 <210> 1 <211> 461 <212> DNA 213 hr3 from Bombys mori nucleopolyhedrovirus <400> 1 acattttatg tcgaaaacaa atgacatcag cttatgattc atacttaatc gtgcgttaca 60 agtagaattc tactcgtaaa gcgagtttaa tttgaaaaac aaattagtca ttattaaaca 120 tgttaacaat cgtgtataaa aatgacatca gtttaatgat gacatcatct cttgattatg 180 ttttacacgt agaattctac tcgtaaagcc agttcagttt tgaaaaacaa atgacatcat 240 ctttcgatta tgttttacac gtagaattct actcgtaaag ccagttcagt tttgaaaaac 300 aaatgacatc atttcttaaa ttcggttttg aaaaacaaat gacatcatct cttgattgtg 360 ttttacacgt agaattctac tcgtaaagcc agttcaattt tgaaaaacaa atgacatcat 420 cttagaggta gactcgtcgc caagacgggt ctgctcatat g 461  

Claims (3)

서열번호 1에 기재된 누에 핵다각체 바이러스 (BmNPV K1 스트레인)로부터 분리한 hr3 엔핸서의 염기서열.Nucleotide sequence of the hr3 enhancer isolated from the silkworm polyhedral virus (BmNPV K1 strain) described in SEQ ID NO: 1. 상기 제 1항의 hr3엔핸서를 단백질 발현운반체 내 적정 도입위치 및 도입방향으로 하여 재조합단백질을 생산하는 방법.A method for producing a recombinant protein by using the hr3 enzyme of claim 1 as an appropriate introduction position and introduction direction in a protein expression carrier. 청구항 2에 있어서, 상기 hr3 엔헨서의 도입방향 및 도입위치는 3’→ 5’방향으로 SV40 폴리 A 하류에 도입하는 것을 특징으로 하는 재조합단백질을 생산하는 방법.The method of claim 2, wherein the introduction direction and introduction position of the hr3 enhancer is introduced downstream of the SV40 poly A in a 3 ′ → 5 ′ direction.
KR1020060133334A 2006-12-26 2006-12-26 Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3 KR20080059702A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060133334A KR20080059702A (en) 2006-12-26 2006-12-26 Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060133334A KR20080059702A (en) 2006-12-26 2006-12-26 Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3

Publications (1)

Publication Number Publication Date
KR20080059702A true KR20080059702A (en) 2008-07-01

Family

ID=39812431

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060133334A KR20080059702A (en) 2006-12-26 2006-12-26 Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3

Country Status (1)

Country Link
KR (1) KR20080059702A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112852876A (en) * 2021-03-04 2021-05-28 西南大学 Silkworm silk gland recombinant expression vector for expressing human epidermal growth factor and preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112852876A (en) * 2021-03-04 2021-05-28 西南大学 Silkworm silk gland recombinant expression vector for expressing human epidermal growth factor and preparation method and application thereof
CN112852876B (en) * 2021-03-04 2022-11-29 西南大学 Silkworm silk gland recombinant expression vector for expressing human epidermal growth factor and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN101619352B (en) Double-probe gene mutation detecting method based on allele special amplification as well as special chip and kit thereof
CN100471956C (en) Novel expression vectors
Arratia-Quijada et al. FlbD, a Myb transcription factor of Aspergillus nidulans, is uniquely involved in both asexual and sexual differentiation
Zeng et al. Duplication of a Pks gene cluster and subsequent functional diversification facilitate environmental adaptation in Metarhizium species
CN109321584B (en) Report system for simply qualitatively/quantitatively detecting working efficiency of single-base gene editing technology
CN107090504B (en) SNP molecular marker combination for corn genotyping and application thereof
CN110791571B (en) SNP marker for distinguishing Vibrio harveyi infection resistance of litopenaeus vannamei, and detection method and application thereof
CN101619351B (en) Method for detecting related gene mutations of diabetes drug treatment as well as special chip and kit thereof
Liu et al. Transcriptome analysis of the brain of the Chinese mitten crab, Eriocheir sinensis, for neuropeptide abundance profiles during ovarian development
Kluge et al. AcAxl2 and AcMst1 regulate arthrospore development and stress resistance in the cephalosporin C producer Acremonium chrysogenum
KR20080059702A (en) Hr3 enhancer from bombyx mori nucleopolyhedrovirus k1 and construction of method for mass production of a recombinant protein using hr3
CN113604495A (en) Explosive molecule biosensor synthesized by utilizing regulating element and preparation method and application thereof
WO2016209037A1 (en) Method for exploring useful genetic resources through bulk metagenome analysis and use thereof
CN110331202A (en) It is a kind of for detecting the kit and method of BRAC1 gene SNP
Matsuo et al. Expression of Asn-d-Trp-Phe-NH2 in the brain of the terrestrial slug Limax valentianus
CN113528686B (en) Reagent and kit for detecting nucleic acid of brucella
KR102144673B1 (en) KASP primer set based on SNP for discriminating Korean melon cultivar and F1 hybrid purity checking and uses thereof
CN114480496B (en) Double-luciferase reporter gene vector for insect cells, construction method, recombinant vector and application
Deepika et al. Molecular diagnostics in sericulture: A paradigm shift towards disease diagnosis in silkworms
CN114182026B (en) Molecular marker related to feed conversion rate of Hu sheep and application of molecular marker
CN114164296B (en) Primer probe composition for detecting pythium oligandrum, kit and application and detection method
CN109486916B (en) Method for detecting allele differential expression
CN114317796B (en) LAMP primer composition for detecting pythium admittedly and detection method thereof
Nichuguti et al. Both the exact target site sequence and a long poly (A) tail are required for precise insertion of the 18S ribosomal DNA-specific non-long terminal repeat retrotransposon R7Ag
Yazdanpanah et al. The development of NESTED-LAMP method as a novel approach for diagnostic purposes while using Leishmania parasite as the study model

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee